You are here:
25 April 2019 / deal

Loyens & Loeff advised Eurazeo Capital on the acquisition of DORC Group from Montagu

Loyens & Loeff advised Eurazeo Capital, a France-based, leading global investment company listed on Euronext Paris, on the acquisition of DORC (Dutch Ophthalmic Research Center) a Netherlands-based company which operates in the medical technology sector and designs, manufactures and distributes ophthalmic surgery equipment, from Montagu Private Equity, a European private equity firm with headquarters in London.

Eurazeo Capital will invest close to 300M€ in this transaction. DORC will be the fifth investment of Eurazeo Capital IV. This investment perfectly fits the strategy presented during the 2018 Annual Results presentation.

Building windows three colors


The statutory cooling-off period

This edition of Quoted discusses the Bill on the introduction of a statutory cooling-off period for listed companies and changes Book 2 of the Dutch Civil Code.... read more

EUTA Special Edition: EU responses to COVID-19 crisis

The COVID-19 (Coronavirus) pandemic is affecting hundreds of thousands of people and is leading, all over the world, to far-reaching health and safety measures.... read more

Update on tax and digitalization

The OECD has made further progress on the design and scope of Pillar One and Two. The European Council has agreed on a COVID-19 recovery package. read more